Frazier Life Sciences Management, L.P.: CYTK position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Frazier Life Sciences Management, L.P. on CYTK, newest first. How the timeline and the estimate are built.
Frazier Life Sciences Management, L.P. held 1,159,879 CYTK shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 1,159,879 sharesChange vs previous 13F 0 shares
2.15% of the 13F portfolio, value $98,810,092.
13F-HR 0001892134-26-000003 filed by Frazier Life Sciences Management, L.P.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 1,159,879 sharesChange vs previous 13F +225,237 shares
1.97% of the 13F portfolio, value $76,447,625.
13F-HR 0001892134-26-000002 filed by Frazier Life Sciences Management, L.P.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 934,642 sharesChange vs previous 13F +44,197 shares
1.6% of the 13F portfolio, value $59,387,153.
13F-HR 0001892134-26-000001 filed by Frazier Life Sciences Management, L.P.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 890,445 sharesChange vs previous 13F +335,714 shares
1.47% of the 13F portfolio, value $48,938,857.
13F-HR 0001892134-25-000012 filed by Frazier Life Sciences Management, L.P.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 554,731 sharesChange vs previous 13F not available
0.73% of the 13F portfolio, value $18,328,312.
13F-HR 0001892134-25-000006 filed by Frazier Life Sciences Management, L.P.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).